Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Executive Interviews

How CEOs and Investors Are Adapting to MDR

The recent extensions of MDR timelines have once again forced companies to recalculate their strategies for operating under the new regulations. Here a panel of CEOs and investors at our recent Dublin Innovation Summit share their perspectives on operating in this ever-changing environment.

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Business Strategies

Great Aspirations: New Mechanical Approaches to Treating Pulmonary Embolism

Pulmonary embolisms are managed by blood thinners, anticoagulants, and thrombolytic drugs, which cannot always resolve the problem and entail their own risks for bleeding complications. In a market with few widely used treatment options, start-ups Althea Medical, Akura Medical, and Magneto Thrombectomy are giving surgeons new minimally invasive tools to remove clots more effectively than ever.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More